Efficacy and safety of mizoribine for the treatment of Sjögren's syndrome: A multicenter open-label clinical trial

Modern Rheumatology

Volumn 17, Issue 6, 2007, Pages 464-469

  Nakayamada, Shingo ^a   Saito, Kazuyoshi ^a   Umehara, Hisanori ^b   Ogawa, Noriyoshi ^b,j   Sumida, Takayuki ^c   Ito, Satoshi ^c   Minota, Seiji ^d   Nara, Hiroyuki ^d   Kondo, Hirobumi ^e,k   Okada, Jun ^f   Mimori, Tsuneyo ^g   Yoshifuji, Hajime ^g   Sano, Hajime ^h   Hashimoto, Naoaki ^h   Sugai, Susumu ⁱ   Tanaka, Yoshiya ^a  

^a UNIVERSITY OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH   (Japan)

^b KANAZAWA MEDICAL UNIVERSITY   (Japan)

^c UNIVERSITY OF TSUKUBA   (Japan)

^d JICHI MEDICAL UNIVERSITY   (Japan)

^e KITASATO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^f KITASATO UNIVERSITY   (Japan)

^g KYOTO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^h HYOGO COLLEGE OF MEDICINE   (Japan)

ⁱ Kudoh Hospital   (Japan)

^j HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^k KITASATO UNIVERSITY MEDICAL CENTER   (Japan)

more..

Author keywords

Mizoribine; Sj gren's syndrome; Xerostomia

Indexed keywords

ANETHOLE TRITHIONE; CEVIMELINE; MIZORIBINE; TRICHLORMETHIAZIDE;

ABDOMINAL PAIN; ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANEMIA; ARTHRALGIA; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BLOOD DISEASE; CLINICAL ASSESSMENT; CLINICAL TRIAL; CONSCIOUSNESS DISORDER; DIARRHEA; DRUG EFFICACY; DRUG ERUPTION; DRUG INDUCED HEADACHE; DRUG SAFETY; DRUG WITHDRAWAL; DRY EYE; FEMALE; GASTROINTESTINAL DISEASE; HEMOGLOBIN BLOOD LEVEL; HUMAN; HYPOKALEMIA; HYPONATREMIA; LACTATE DEHYDROGENASE BLOOD LEVEL; LEUKOCYTE COUNT; LIVER DYSFUNCTION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NAUSEA; PRIORITY JOURNAL; PRURITUS; SALIVATION; SIDE EFFECT; SJOEGREN SYNDROME; URIC ACID BLOOD LEVEL; VISUAL ANALOG SCALE; VOMITING; XEROSTOMIA;

AGED; DEGLUTITION DISORDERS; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; IMP DEHYDROGENASE; MALE; MIDDLE AGED; RIBONUCLEOSIDES; SALIVA; SALIVATION; SJOGREN'S SYNDROME; TREATMENT OUTCOME; XEROPHTHALMIA;

EID: 37449023679     PISSN: 14397595     EISSN: 14397609     Source Type: Journal    
DOI: 10.1007/s10165-007-0627-2     Document Type: Article

References (11)

1. CP Mavragani NM Moutsopoulos HM Moutsopoulos 2006 The management of Sjögren's syndrome Nat Clin Pract Rheumatol 2 252-61 16932698 10.1038/ncprheum0165 1:CAS:528:DC%2BD28Xltlaguro%3D
2. RI Fox 2005 Sjögren's syndrome Lancet 366 321-31 16039337 10.1016/ S0140-6736(05)66990-5 1:CAS:528:DC%2BD2MXmsVWkur4%3D
3. S Nakayamada K Saito K Nakatsuka K Nakano M Tokunaga N Sawamukai 2003 Efficacy of mizoribine treatment in patients with Sjögren's syndrome: An open trial Mod Rheumatol 13 339-45 10.1007/ s10165-003-0247-4 1:CAS:528:DC%2BD3sXhtVSjsb3J
4. K Torikai 2002 Special Issue: New topics on Sjögren's syndrome. IV. Laboratory tests: 1. Saxon test, gum test, and ophthalmologic examinations (in Japanese) Prog Med 22 43-6
5. SD Steinfeld P Demols T Appelboom 2002 Infliximab in primary Sjögren's syndrome: One-year followup Arthritis Rheum 46 3301-3 12483735 10.1002/art.10674 1:CAS:528:DC%2BD3sXjslGhsQ%3D%3D
6. X Mariette P Ravaud S Steinfeld G Baron J Goetz E Hachulla 2004 Inefficacy of infliximab in primary Sjögren's syndrome: Results of the Randomized, Controlled Trial of Remicade in Primary Sjögren's Syndrome (TRIPSS) Arthritis Rheum 50 1270-6 15077311 10.1002/art.20146 1:CAS:528:DC%2BD2cXjslGqsL4%3D
7. V Sankar MT Brennan MR Kok RA Leakan JA Smith J Manny 2004 Etanercept in Sjögren's syndrome: A twelve-week randomized, double-blind, placebo-controlled pilot clinical trial Arthritis Rheum 50 2240-5 15248223 10.1002/art.20299 1:CAS:528:DC%2BD2cXmsVansbg%3D
8. M Okubo X Chen K Kamata Y Masaki T Uchiyama 1986 Suppressive effect of mizoribine on humoral antibody production in DBA/2 mice Transplantation 41 495-8 3485844 10.1097/00007890-198604000-00016 1:CAS:528:DyaL28Xhs1Wksro%3D
9. LA Turka J Dayton G Sinclair CB Thompson BS Mitchell 1991 Guanine ribonucleotide depletion inhibits T cell activation J Clin Invest 87 940-8 1999502 1:CAS:528:DyaK3MXhsFKrsrg%3D
10. +B) in rheumatoid arthritis and primary Sjögren's syndrome I Clin Exp Immunol 77 175-8 2476268 1:STN:280:BiaA2snpsVc%3D
11. Y Shiokawa M Honma K Shichikawa T Miyamoto J Hirose T Nobunaga 1991 Clinical evaluation of the immunosuppressant mizoribine for treatment of rheumatoid arthritis: A multicenter double-blind placebo-controlled trial based on basal treatment(in Japanese) J Clin Expt Med 156 811-31